Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
ACS Appl Mater Interfaces ; 16(8): 10590-10600, 2024 Feb 28.
Artigo em Inglês | MEDLINE | ID: mdl-38343039

RESUMO

To inhibit viral infection, it is necessary for the surface of polypropylene (PP), a polymer of significant industrial relevance, to possess biocidal properties. However, due to its low surface energy, PP weakly interacts with other organic molecules. The biocidal effects of quaternary ammonium compounds (QACs) have inspired the development of nonwoven PP fibers with surface-bound quaternary ammonium (QA). Despite this advancement, there is limited knowledge regarding the durability of these coatings against scratching and abrasion. It is hypothesized that the durability could be improved if the thickness of the coating layer were controlled and increased. We herein functionalized PP with three-dimensionally surface-grafted poly(N-benzyl-4-vinylpyridinium bromide) (PBVP) by a simple and rapid method involving graft polymerization and benzylation and examined the influence of different factors on the antiviral effect of the resulting plastic by using a plaque assay. The thickness of the PBVP coating, surface roughness, and amount of QACs, which jointly determine biocidal activity, could be controlled by adjusting the duration and intensity of the ultraviolet irradiation used for grafting. The best-performing sample reduced the viral infection titer of an enveloped model virus (bacteriophage ϕ6) by approximately 5 orders of magnitude after 60 min of contact and retained its antiviral activity after surface polishing-simulated scratching and abrasion, which indicated the localization of QACs across the coating interior. Our method may expand the scope of application to resin plates as well as fibers of PP. Given that the developed approach is not limited to PP and may be applied to other low-surface-energy olefinic polymers such as polyethylene and polybutene, our work paves the way for the fabrication of a wide range of biocidal surfaces for use in diverse environments, helping to prevent viral infection.


Assuntos
Polipropilenos , Polivinil , Compostos de Piridínio , Compostos de Vinila , Viroses , Humanos , Polipropilenos/farmacologia , Compostos de Amônio Quaternário/farmacologia , Polímeros/farmacologia , Antivirais/farmacologia
2.
ACS Appl Mater Interfaces ; 15(16): 20398-20409, 2023 Apr 26.
Artigo em Inglês | MEDLINE | ID: mdl-36947007

RESUMO

Antiviral coatings that inactivate a broad spectrum of viruses are important in combating the evolution and emergence of viruses. In this study, nano-columnar Cu thin films have been proposed, inspired by cicada wings (which exhibit mechano-bactericidal activity). Nano-columnar thin films of Cu and its oxides were fabricated by the sputtering method, and their antiviral activities were evaluated against envelope-type bacteriophage Φ6 and non-envelope-type bacteriophage Qß. Among all of the fabricated films, Cu thin films showed the highest antiviral activity. The infectious activity of the bacteriophages was reduced by 5 orders of magnitude within 30 min by the Cu thin films, by 3 orders of magnitude by the Cu2O thin films, and by less than 1 order of magnitude by the CuO thin films. After exposure to ambient air for 1 month, the antiviral activity of the Cu2O thin film decreased by 1 order of magnitude; the Cu thin films consistently maintained a higher antiviral activity than the Cu2O thin films. Subsequently, the surface oxidation states of the thin films were analyzed by X-ray photoelectron spectroscopy; Cu thin films exhibited slower oxidation to the CuO than Cu2O thin films. This oxidation resistance could be a characteristic property of nanostructured Cu fabricated by the sputtering method. Finally, the antiviral activity of the nano-columnar Cu thin films against infectious viruses in humans was demonstrated by the binding inhibition of the SARS-CoV-2 spike protein to the angiotensin-converting enzyme 2 receptor within 10 min.


Assuntos
Bacteriófagos , COVID-19 , Humanos , Antivirais/farmacologia , Cobre/farmacologia , Cobre/química , SARS-CoV-2
3.
ACS Appl Bio Mater ; 6(3): 1032-1040, 2023 03 20.
Artigo em Inglês | MEDLINE | ID: mdl-36780326

RESUMO

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) caused a pandemic in 2019 and reaffirmed the importance of environmental sanitation. To prevent the spread of viral infections, we propose the application of a mesoporous silica (MS)-based virus-inactivating material. MS is typically synthesized using a micellar surfactant template; hence, the intermediate before removal of the surfactant template is expected to have a virus-inactivating activity. MS-CTAC particles filled with cetyltrimethylammonium chloride (CTAC), a cationic surfactant with an alkyl chain length of 16, were used to test this hypothesis. Plaque assays revealed that the MS-CTAC particles inactivated the enveloped bacteriophage φ6 by approximately 4 orders of magnitude after a contact time of 10 min. The particles also indicated a similar inactivation effect on the nonenveloped bacteriophage Qß. In aqueous solution, CTAC loaded on MS-CTAC was released until the equilibrium concentration of loading and release on MS was reached. The released CTAC acted on viruses. Thus, MS is likely a good reservoir for the micellar surfactant. Surfactant readsorption also occurred in the MS particles, and the highest retention rate was observed when micellar surfactants with alkyl chain lengths appropriate for the pore size were used. The paper containing MS-CTAC particles was shown to maintain stable viral inactivation for at least three months in a typical indoor environment. Applying this concept to indoor wallpaper and air-conditioning filters could contribute to the inactivation of viruses in aerosols. These findings open possibilities for mesoporous materials with high surface areas, which can further develop into virus inactivation materials.


Assuntos
COVID-19 , Tensoativos , Humanos , Tensoativos/farmacologia , Inativação de Vírus , SARS-CoV-2 , Cetrimônio , Micelas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...